E-poster No. / 壁報編號
C12
Title / 題目
Exploring the Clinical Impact of Antiresorptive Agents on Patients with Primary Breast Cancer Receiving Endocrine Therapy
First Author / 第一作者
Sheng-Fan Wang
Institution / 單位
Department of Pharmacy, Taipei Veterans General Hospital, Taipei 112, Taiwan, R.O.C.
Audio / 音訊檔
Author Group / 作者群
Sheng-Fan Wang, Ph.D.1 Yi-Sheng Lin, M.S.1 Yuh-Lih Chang, Ph.D.1 Chian-Ying Chou, Ph.D.1 Wan-Yu Yeh, Ph.D.2 Chern-En Chiang, M.D., Ph.D.3 Chen-Huan Chen, M.D., Ph.D.4 Ling-Ming Tseng, M.D.5* Hsin-Chen Lee, Ph.D.6 Shiaun Chen, Ph.D.7 Chun-Yu Liu, M.D., Ph.D.8* Hao-Min Cheng, M.D., Ph.D.9*
Author Group Institution/ 作者群單位
1 Department of Pharmacy, Taipei Veterans General Hospital, Taipei 112, Taiwan, R.O.C.
2 Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei 112, Taiwan, R.O.C
3 General Clinical Research Center, Taipei Veterans General Hospital, Taipei 112, Taiwan, R.O.C.
4 School of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei 112, Taiwan, R.O.C.
5 Department of Surgery, Taipei Veterans General Hospital, Taipei 112, Taiwan, R.O.C.
6 Department and Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan, R.O.C.
7 Department of Cancer Biology and Molecular Medicine, Beckman Research Institute, City of Hope, USA
8 Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan, R.O.C.
9 Department of Medical Education, Taipei Veterans General Hospital, Taipei 112, Taiwan, R.O.C.
Category / 主題分類
Clinical Research
Keyword / 關鍵字
antiresorptive agent, early breast cancer, endocrine therapy resistance, bisphosphonate, aromatase inhibitor
